Copyright Reports & Markets. All rights reserved.

Global Point-of-Care Genetic Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Point-of-Care Genetic Testing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Point-of-Care Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 POCT Cancer Kits
    • 1.4.3 Molecular POC Kits
    • 1.4.4 POCT In Antibiotic Therapies
    • 1.4.5 Assay Cartridge
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Point-of-Care Genetic Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostic Labs
    • 1.5.3 Bio-Pharmaceutical Industry
    • 1.5.4 Academic Institutions
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Point-of-Care Genetic Testing Market Perspective (2015-2026)
  • 2.2 Global Point-of-Care Genetic Testing Growth Trends by Regions
    • 2.2.1 Point-of-Care Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Point-of-Care Genetic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Point-of-Care Genetic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Point-of-Care Genetic Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Point-of-Care Genetic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Point-of-Care Genetic Testing Players by Market Size
    • 3.1.1 Global Top Point-of-Care Genetic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Point-of-Care Genetic Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Point-of-Care Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Point-of-Care Genetic Testing Market Concentration Ratio
    • 3.2.1 Global Point-of-Care Genetic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Point-of-Care Genetic Testing Revenue in 2019
  • 3.3 Point-of-Care Genetic Testing Key Players Head office and Area Served
  • 3.4 Key Players Point-of-Care Genetic Testing Product Solution and Service
  • 3.5 Date of Enter into Point-of-Care Genetic Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Point-of-Care Genetic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Point-of-Care Genetic Testing Market Size by Application (2015-2020)
  • 5.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Point-of-Care Genetic Testing Market Size (2015-2020)
  • 6.2 Point-of-Care Genetic Testing Key Players in North America (2019-2020)
  • 6.3 North America Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 6.4 North America Point-of-Care Genetic Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Point-of-Care Genetic Testing Market Size (2015-2020)
  • 7.2 Point-of-Care Genetic Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 7.4 Europe Point-of-Care Genetic Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Point-of-Care Genetic Testing Market Size (2015-2020)
  • 8.2 Point-of-Care Genetic Testing Key Players in China (2019-2020)
  • 8.3 China Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 8.4 China Point-of-Care Genetic Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Point-of-Care Genetic Testing Market Size (2015-2020)
  • 9.2 Point-of-Care Genetic Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 9.4 Japan Point-of-Care Genetic Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Point-of-Care Genetic Testing Market Size (2015-2020)
  • 10.2 Point-of-Care Genetic Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Point-of-Care Genetic Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Point-of-Care Genetic Testing Market Size (2015-2020)
  • 11.2 Point-of-Care Genetic Testing Key Players in India (2019-2020)
  • 11.3 India Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 11.4 India Point-of-Care Genetic Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Point-of-Care Genetic Testing Market Size (2015-2020)
  • 12.2 Point-of-Care Genetic Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Point-of-Care Genetic Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Point-of-Care Genetic Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott (US)
    • 13.1.1 Abbott (US) Company Details
    • 13.1.2 Abbott (US) Business Overview
    • 13.1.3 Abbott (US) Point-of-Care Genetic Testing Introduction
    • 13.1.4 Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020))
    • 13.1.5 Abbott (US) Recent Development
  • 13.2 Roche (Switzerland)
    • 13.2.1 Roche (Switzerland) Company Details
    • 13.2.2 Roche (Switzerland) Business Overview
    • 13.2.3 Roche (Switzerland) Point-of-Care Genetic Testing Introduction
    • 13.2.4 Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.2.5 Roche (Switzerland) Recent Development
  • 13.3 Thermo Fisher Scientific (US)
    • 13.3.1 Thermo Fisher Scientific (US) Company Details
    • 13.3.2 Thermo Fisher Scientific (US) Business Overview
    • 13.3.3 Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Introduction
    • 13.3.4 Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.3.5 Thermo Fisher Scientific (US) Recent Development
  • 13.4 Cepheid (US)
    • 13.4.1 Cepheid (US) Company Details
    • 13.4.2 Cepheid (US) Business Overview
    • 13.4.3 Cepheid (US) Point-of-Care Genetic Testing Introduction
    • 13.4.4 Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.4.5 Cepheid (US) Recent Development
  • 13.5 IQuum (US)
    • 13.5.1 IQuum (US) Company Details
    • 13.5.2 IQuum (US) Business Overview
    • 13.5.3 IQuum (US) Point-of-Care Genetic Testing Introduction
    • 13.5.4 IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.5.5 IQuum (US) Recent Development
  • 13.6 Biocartis (Switzerland)
    • 13.6.1 Biocartis (Switzerland) Company Details
    • 13.6.2 Biocartis (Switzerland) Business Overview
    • 13.6.3 Biocartis (Switzerland) Point-of-Care Genetic Testing Introduction
    • 13.6.4 Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.6.5 Biocartis (Switzerland) Recent Development
  • 13.7 Idaho Technologies (US)
    • 13.7.1 Idaho Technologies (US) Company Details
    • 13.7.2 Idaho Technologies (US) Business Overview
    • 13.7.3 Idaho Technologies (US) Point-of-Care Genetic Testing Introduction
    • 13.7.4 Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.7.5 Idaho Technologies (US) Recent Development
  • 13.8 Optigene (UK)
    • 13.8.1 Optigene (UK) Company Details
    • 13.8.2 Optigene (UK) Business Overview
    • 13.8.3 Optigene (UK) Point-of-Care Genetic Testing Introduction
    • 13.8.4 Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.8.5 Optigene (UK) Recent Development
  • 13.9 Lumora (UK)
    • 13.9.1 Lumora (UK) Company Details
    • 13.9.2 Lumora (UK) Business Overview
    • 13.9.3 Lumora (UK) Point-of-Care Genetic Testing Introduction
    • 13.9.4 Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
    • 13.9.5 Lumora (UK) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Point-of-Care Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-Care Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott (US)
    Roche (Switzerland)
    Thermo Fisher Scientific (US)
    Cepheid (US)
    IQuum (US)
    Biocartis (Switzerland)
    Idaho Technologies (US)
    Optigene (UK)
    Lumora (UK)

    Market segment by Type, the product can be split into
    POCT Cancer Kits
    Molecular POC Kits
    POCT In Antibiotic Therapies
    Assay Cartridge
    Other
    Market segment by Application, split into
    Diagnostic Labs
    Bio-Pharmaceutical Industry
    Academic Institutions
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now